Received Jun 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 37KR7 | IM / LL |
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | 4 | UK230AA | IM / LL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y017528 | SC / RL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 4 | MH1445 | IM / RL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Z004246 | SC / LL |
Patient presented for evaluation of a rash which developed 4 days ago. Rash was initially itchy, flat rash evolving into bumps. On 6/17, rash spreading, with one lesion now more widespread. No signs of pain or fever, normal appetite. No medications administered for the rash. Child observed scratching affected area. Skin examination: multiple lesions on left hip - small vesicles some are grouped - possible tenderness. Some lesions fluid filled some open and crusting - erythematous base, Lesions: Itchy and spreading - also tender.
None
None
None
None
6/17/2026: Culture and PCR Test, Varicella zoster virus detected